Cancer genomics and pathology: All Together Now

Pathology International

Volumn 62, Issue 10, 2012, Pages 647-659

  Shibata, Tatsuhiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cancer genome sequencing; Cancer transcriptome sequencing; Chromothripsis; Kataegis; Next generation sequencing; Tumor evolution

Indexed keywords

BETA CATENIN; ISOCITRATE DEHYDROGENASE 1; NOTCH RECEPTOR; PROTEIN P53;

ACUTE GRANULOCYTIC LEUKEMIA; BRAIN TUMOR; BREAST CANCER; CANCER GENETICS; CANCER GENOMICS; CANCER PATHOLOGY; CHRONIC LYMPHATIC LEUKEMIA; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EXOME; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOMICS; GLIOBLASTOMA; HISTONE MODIFICATION; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG CANCER; LUNG SMALL CELL CANCER; MEDICAL DECISION MAKING; MELANOMA; MULTIPLE CANCER; MYELODYSPLASTIC SYNDROME; NEOPLASM; NEXT GENERATION SEQUENCING; NONHODGKIN LYMPHOMA; ONCOGENE; ONCOGENE ADDICTION; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SINGLE CELL SEQUENCING; SOLID TUMOR; WHOLE EXOME SEQUENCING; WHOLE TRANSCRIPTOME SEQUENCING;

GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INDIVIDUALIZED MEDICINE; MUTATION; NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 84866759569     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02855.x     Document Type: Review

References (101)

1. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009; 458: 719-24.
2. Greenman C, Stephens P, Smith R etal. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446: 153-8.
3. Hahn WC, Counter CM, Lundberg AS etal. Creation of human tumour cells with defined genetic elements. Nature 1999; 400: 464-8.
4. Weinstein IB. Cancer. Addiction to oncogenes-The Achilles heal of cancer. Science 2002; 297: 63-4.
5. Shachaf CM, Kopelman AM, Arvanitis C etal. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004; 431: 1112-7.
6. Chin L, Andersen JN, Futreal PA. Cancer genomics: From discovery science to personalized medicine. Nat Med 2011; 17: 297-303.
7. Lynch TJ, Bell DW, Sordella R etal. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129-39.
8. Solit DB, Garraway LA, Pratilas CA etal. BRAF mutation predicts sensitivity to MEK inhibition. Nature 2006; 439: 358-62.
9. Kwak EL, Bang YJ, Camidge DR etal. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010; 363: 1693-703.
10. Friend SH, Bernards R, Rogelj S etal. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643-6.
11. Nishisho I, Nakamura Y, Miyoshi Y etal. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-9.
12. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
13. Davies H, Bignell GR, Cox C etal. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-54.
14. Paez JG, Jänne PA, Lee JC etal. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 2004; 304: 1497-500.
15. Bentley DR, Balasubramanian S, Swerdlow HP etal. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 2008; 456: 53-9.
16. Korbel JO, Urban AE, Affourtit JP etal. Paired-end mapping reveals extensive structural variation in the human genome. Science 2007; 318: 420-6.
17. Maher CA, Kumar-Sinha C, Cao X etal. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009; 458: 97-101.
18. Hodges E, Xuan Z, Balija V etal. Genome-wide in situ exon capture for selective resequencing. Nat Genet 2007; 39: 1522-7.
19. Gnirke A, Melnikov A, Maguire J etal. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 2009; 27: 182-9.
20. Navin N, Kendall J, Troge J etal. Tumour evolution inferred by single-cell sequencing. Nature 2011; 472: 90-4.
21. Hou Y, Song L, Zhu P etal. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 2012; 148: 873-85.
22. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609-15.
23. Forbes SA, Bindal N, Bamford S etal. COSMIC: Mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011; 39 (database issue): D945-50.
24. International Cancer Genome Consortium. International network of cancer genome projects. Nature 2010; 464: 993-8.
25. Ley TJ, Mardis ER, Ding L etal. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008; 456: 66-72.
26. Mardis ER, Ding L, Dooling DJ etal. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361: 1058-66.
27. Ley TJ, Ding L, Walter MJ etal. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010; 363: 2424-33.
28. Walter MJ, Shen D, Ding L etal. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 2012; 366: 1090-8.
29. Yoshida K, Sanada M, Shiraishi Y etal. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64-9.
30. Graubert TA, Shen D, Ding L etal. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet 2011; 44: 53-7.
31. Papaemmanuil E, Cazzola M, Boultwood J etal. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011; 365: 1384-95.
32. Puente XS, Pinyol M, Quesada V etal. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101-5.
33. Quesada V, Conde L, Villamor N etal. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2011; 44: 47-52.
34. Wang L, Lawrence MS, Wan Y etal. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011; 365: 2497-506.
35. Morin RD, Mendez-Lago M, Mungall AJ etal. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476: 298-303.
36. Pasqualucci L, Trifonov V, Fabbri G etal. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011; 43: 830-7.
37. Zhang J, Ding L, Holmfeldt L etal. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157-63.
38. Chapman MA, Lawrence MS, Keats JJ etal. Initial genome sequencing and analysis of multiple myeloma. Nature 2011; 471: 467-72.
39. Tiacci E, Trifonov V, Schiavoni G etal. BRAF mutations in hairy-cell leukemia. N Engl J Med 2011; 364: 2305-15.
40. Koskela HL, Eldfors S, Ellonen P etal. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 2012; 366: 1905-13.
41. Totoki Y, Tatsuno K, Yamamoto S etal. High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet 2011; 43: 464-9.
42. Fujimoto A, Totoki Y, Abe T etal. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 2012; 44: 760-4.
43. Li M, Zhao H, Zhang X etal. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 2011; 43: 828-9.
44. Guichard C, Amaddeo G, Imbeaud S etal. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 2012; 44: 694-8.
45. Sung WK, Zheng H, Li S etal. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 2012; 44: 765-9.
46. Sørlie T, Perou CM, Tibshirani R etal. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10869-74.
47. Wood LD, Parsons DW, Jones S etal. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318: 1108-13.
48. Shah SP, Morin RD, Khattra J etal. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009; 461: 809-13.
49. Stephens PJ, McBride DJ, Lin ML etal. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 2009; 462: 1005-10.
50. Ding L, Ellis MJ, Li S etal. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010; 464: 999-1005.
51. Stephens PJ, Tarpey PS, Davies H etal. The landscape of cancer genes and mutational processes in breast cancer. Nature 2012; 486: 400-4.
52. Nik-Zainal S, Alexandrov LB, Wedge DC etal. Mutational processes molding the genomes of 21 breast cancers. Cell 2012; 149: 979-93.
53. Pleasance ED, Cheetham RK, Stephens PJ etal. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010; 463: 191-6.
54. Nikolaev SI, Rimoldi D, Iseli C etal. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet 2011; 44: 133-9.
55. Wei X, Walia V, Lin JC etal. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 2011; 43: 442-6.
56. Stark MS, Woods SL, Gartside MG etal. Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nat Genet 2011; 44: 165-9.
57. Berger MF, Hodis E, Heffernan TP etal. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 2012; 485: 502-6.
58. Harbour JW, Onken MD, Roberson ED etal. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010; 330: 1410-3.
59. Wiesner T, Obenauf AC, Murali R etal. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 2011; 43: 1018-21.
60. Ding L, Getz G, Wheeler DA etal. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455: 1069-75.
61. Pleasance ED, Stephens PJ, O'Meara S etal. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010; 463: 184-90.
62. Lee W, Jiang Z, Liu J etal. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 2010; 465: 473-7.
63. Ju YS, Lee WC, Shin JY etal. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res 2012; 22: 436-45.
64. Jones S, Zhang X, Parsons DW etal. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321: 1801-6.
65. Wang L, Tsutsumi S, Kawaguchi T etal. Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency. Genome Res 2012; 22: 208-19.
66. Bass AJ, Lawrence MS, Brace LE etal. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet 2011; 43: 964-8.
67. Jiao Y, Shi C, Edil BH etal. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 2011; 331: 1199-203.
68. Heaphy CM, de Wilde RF, Jiao Y etal. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011; 333: 425.
69. Wang K, Kan J, Yuen ST etal. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat Genet 2011; 43: 1219-23.
70. Zang ZJ, Cutcutache I, Poon SL etal. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet 2012; 44: 570-4.
71. Parsons DW, Jones S, Zhang X etal. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807-12.
72. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455: 1061-8.
73. Schwartzentruber J, Korshunov A, Liu XY etal. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012; 482: 226-31.
74. Bettegowda C, Agrawal N, Jiao Y etal. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 2011; 333: 1453-5.
75. Rausch T, Jones DT, Zapatka M etal. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 2012; 148: 59-71.
76. Dalgliesh GL, Furge K, Greenman C etal. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010; 463: 360-3.
77. Varela I, Tarpey P, Raine K etal. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011; 469: 539-42.
78. Guo G, Gui Y, Gao S etal. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet 2011; 44: 17-9.
79. Berger MF, Lawrence MS, Demichelis F etal. The genomic complexity of primary human prostate cancer. Nature 2011; 470: 214-20.
80. Kumar A, White TA, MacKenzie AP etal. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc Natl Acad Sci U S A 2011; 108: 17087-92.
81. Barbieri CE, Baca SC, Lawrence MS etal. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 2012; 44: 685-9.
82. Grasso CS, Wu YM, Robinson DR etal. The mutational landscape of lethal castration-resistant prostate cancer. Nature 2012; 487: 239-43.
83. Jones S, Wang TL, IeM S etal. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010; 330: 228-31.
84. Ong CK, Subimerb C, Pairojkul C etal. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet 2012; 44: 690-3.
85. Agrawal N, Frederick MJ, Pickering CR etal. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011; 333: 1154-7.
86. Mäkinen N, Mehine M, Tolvanen J etal. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 2011; 334: 252-5.
87. Molenaar JJ, Koster J, Zwijnenburg DA etal. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 2012; 483: 589-93.
88. Zhang J, Benavente CA, McEvoy J etal. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 2012; 481: 329-34.
89. Barretina J, Caponigro G, Stransky N etal. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483: 603-7.
90. Gerlinger M, Rowan AJ, Horswell S etal. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-92.
91. Xu X, Hou Y, Yin X etal. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 2012; 148: 886-95.
92. Yachida S, Jones S, Bozic I etal. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467: 1114-7.
93. Campbell PJ, Yachida S, Mudie LJ etal. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010; 467: 1109-13.
94. Ding L, Ley TJ, Larson DE etal. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012; 481: 506-10.
95. Palanisamy N, Ateeq B, Kalyana-Sundaram S etal. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med 2010; 16: 793-8.
96. Robinson DR, Kalyana-Sundaram S, Wu YM etal. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med 2011; 17: 1646-51.
97. Kohno T, Ichikawa H, Totoki Y etal. KIF5B-RET fusions in lung adenocarcinoma. Nat Med 2012; 18: 375-7.
98. Shah SP, Köbel M, Senz J etal. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 2009; 360: 2719-29.
99. Heravi-Moussavi A, Anglesio MS, Cheng SW etal. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 2012; 366: 234-42.
100. Prensner JR, Iyer MK, Balbin OA etal. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 2011; 29: 742-9.
101. Stephens PJ, Greenman CD, Fu B etal. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011; 144: 27-40.